TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

success, page-12

  1. loloagain
    180 Posts.
    clock Created with Sketch.
    01/11/11
    10:16
    Post #: 9222592
    Granted, we didn't get the Device classification we were hoping for, and being classed a "Biologic" will add a bit more overhead to things - but it's still excellent news to have clarity for the path forward in the US.

    Must say the release has been brilliantly spun though...very impressed with whomever put that together.

    Onward & Upward we hope.

    Regards

    DYOR
    GLTA
    TIS Price at posting: 60.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.